Generated Narrative: CodeSystem kpsd-treatment-codes This case-sensitive code system https://fhir.dha.go.ke/ig/emergency/CodeSystem/kpsd-treatment-codes defines the following codes: Code Display Definition KPS.D.DE.1 Medication Reason Clinical reason for prescribing or using the medication (linked to a health condition) KPS.D.DE.2 Intended Use Purpose such as prevention, treatment, diagnostic, anaesthesia, or equipment care KPS.D.DE.3 Medication Name/Code Medication administered or intended for administration medicationStatus Medication Status Availability status of the medication medicationStatusActive Active The medication is currently in use medicationStatusInactive Inactive The medication is not currently in use medicationStatusError Entered in Error The medication was recorded by mistake medicationForm Medication Form Form of the medication (e.g., tablet, capsule, powder) KPS.D.DE.3.4 Tablet Solid dose form intended for oral administration. KPS.D.DE.3.5 Capsule Oral dosage form in a gelatin shell. KPS.D.DE.3.6 Liquid Oral or injectable solution/suspension dosage form. KPS.D.DE.3.7 Powder Dry substance that can be reconstituted or used directly. KPS.D.DE.4 Active Ingredient List Substance(s) that produce therapeutic effect (e.g., paracetamol) KPS.D.DE.4.1 Paracetamol Common analgesic and antipyretic agent. KPS.D.DE.4.2 Amoxicillin Broad-spectrum beta-lactam antibiotic. KPS.D.DE.4.3 Metronidazole Antibiotic and antiprotozoal medication. KPS.D.DE.4.4 Ibuprofen NSAID used for pain relief, fever, and inflammation. KPS.D.DE.4.5 Artemether + Lumefantrine Antimalarial combination therapy. KPS.D.DE.5 Strength Dosage strength of active ingredient (e.g., 500mg/tablet) KPS.D.DE.7 Dosage Regimen Dosing schedule: amount, frequency, duration (e.g., 1 tablet every 24h for 10 days) KPS.D.DE.8 Route of Administration Pathway for administering the product (e.g., oral, intravenous) KPS.D.DE.9 Date of Onset of Treatment Start date for prescribed medication use KPS.D.DE.10 Plan of Care Narrative of therapeutic plans including diet, exercise, surgery, goals, and follow-ups KPS.D.DE.11 External Reference Link to guidelines such as CPGs, emergency protocols, or other clinically relevant references KPS.D.DE.12 Related With Indicates which Patient Summary entries this information relates to (e.g., link to a rare disease entry)
CodeSystem representing treatment and medication-related data elements under the Kenya Patient Summary (KPS.D).
Clinical reason for prescribing or using the medication (linked to a health condition)
Purpose such as prevention, treatment, diagnostic, anaesthesia, or equipment care
Medication administered or intended for administration
Form of the medication (e.g., tablet, capsule, powder)
Solid dose form intended for oral administration.
Oral or injectable solution/suspension dosage form.
Dry substance that can be reconstituted or used directly.
Substance(s) that produce therapeutic effect (e.g., paracetamol)
Antibiotic and antiprotozoal medication.
NSAID used for pain relief, fever, and inflammation.
Dosage strength of active ingredient (e.g., 500mg/tablet)
Dosing schedule: amount, frequency, duration (e.g., 1 tablet every 24h for 10 days)
Pathway for administering the product (e.g., oral, intravenous)
Start date for prescribed medication use
Narrative of therapeutic plans including diet, exercise, surgery, goals, and follow-ups
Link to guidelines such as CPGs, emergency protocols, or other clinically relevant references
Indicates which Patient Summary entries this information relates to (e.g., link to a rare disease entry)